Rubén Varela‐Calviño

CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

Ania Skowera, Richard J. Ellis, Rubén Varela‐Calviño et al. · Journal of Clinical Investigation · 2008 · 360 citations · Full text

Cellular Immune Activation in Gulf War Veterans

Anna Skowera, Matthew Hotopf, Elżbieta Sawicka et al. · Journal of Clinical Immunology · 2004 · 71 citations

Inflammation, Cellular Immune Activation, Medicine +7

Endogenous Enzymatic Activities of the Avian Reovirus S1133: Identification of the Viral Capping Enzyme

José Martı́nez-Costas, Rubén Varela‐Calviño, Javier Benavente · Virology · 1995 · 48 citations

Avian Reovirus S1133, Molecular Virology, Pathogenesis +6

Characterization of the T-Cell Response to Coxsackievirus B4

Rubén Varela‐Calviño, Richard J. Ellis, Gianluca Sgarbi et al. · Diabetes · 2002 · 45 citations · Full text

Healthy Subjects, Viral Pathogenesis, Immunology +16

Dry Powder Comprised of Isoniazid-Loaded Nanoparticles of Hyaluronic Acid in Conjugation with Mannose-Anchored Chitosan for Macrophage-Targeted Pulmonary Administration in Tuberculosis

Mahwash Mukhtar, Noémi Csaba, Sandra Robla et al. · Pharmaceutics · 2022 · 37 citations · Full text

Nanoparticles, Nanomedicine, Engineering +14